These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 28539261)
21. Propranolol increases vascular permeability through pericyte apoptosis and exacerbates oxygen-induced retinopathy. Yun JH; Koh YJ; Jeong HS; Lee DH; Lee EH; Cho CH Biochem Biophys Res Commun; 2018 Sep; 503(4):2792-2799. PubMed ID: 30100069 [TBL] [Abstract][Full Text] [Related]
22. Endothelial Dysfunction in Diabetic Retinopathy. Gui F; You Z; Fu S; Wu H; Zhang Y Front Endocrinol (Lausanne); 2020; 11():591. PubMed ID: 33013692 [TBL] [Abstract][Full Text] [Related]
23. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R. Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864 [TBL] [Abstract][Full Text] [Related]
24. G-protein-coupled receptor 91 and succinate are key contributors in neonatal postcerebral hypoxia-ischemia recovery. Hamel D; Sanchez M; Duhamel F; Roy O; Honoré JC; Noueihed B; Zhou T; Nadeau-Vallée M; Hou X; Lavoie JC; Mitchell G; Mamer OA; Chemtob S Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):285-93. PubMed ID: 24285580 [TBL] [Abstract][Full Text] [Related]
25. Iron Overload Accelerates the Progression of Diabetic Retinopathy in Association with Increased Retinal Renin Expression. Chaudhary K; Promsote W; Ananth S; Veeranan-Karmegam R; Tawfik A; Arjunan P; Martin P; Smith SB; Thangaraju M; Kisselev O; Ganapathy V; Gnana-Prakasam JP Sci Rep; 2018 Feb; 8(1):3025. PubMed ID: 29445185 [TBL] [Abstract][Full Text] [Related]
26. Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1α Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy. Wei J; Jiang H; Gao H; Wang G Cell Physiol Biochem; 2016; 40(6):1570-1577. PubMed ID: 27997905 [TBL] [Abstract][Full Text] [Related]
27. Role of macular xanthophylls in prevention of common neovascular retinopathies: retinopathy of prematurity and diabetic retinopathy. Gong X; Rubin LP Arch Biochem Biophys; 2015 Apr; 572():40-48. PubMed ID: 25701588 [TBL] [Abstract][Full Text] [Related]
28. VEGF as a Trophic Factor for Müller Glia in Hypoxic Retinal Diseases. Fu S; Dong S; Zhu M; Le YZ Adv Exp Med Biol; 2018; 1074():473-478. PubMed ID: 29721978 [TBL] [Abstract][Full Text] [Related]
29. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina. Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026 [TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Lashkari K; Hirose T; Yazdany J; McMeel JW; Kazlauskas A; Rahimi N Am J Pathol; 2000 Apr; 156(4):1337-44. PubMed ID: 10751359 [TBL] [Abstract][Full Text] [Related]
32. VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. McColm JR; Geisen P; Hartnett ME Mol Vis; 2004 Jul; 10():512-20. PubMed ID: 15303088 [TBL] [Abstract][Full Text] [Related]
33. Short-term treatment with VEGF receptor inhibitors induces retinopathy of prematurity-like abnormal vascular growth in neonatal rats. Nakano A; Nakahara T; Mori A; Ushikubo H; Sakamoto K; Ishii K Exp Eye Res; 2016 Feb; 143():120-31. PubMed ID: 26500193 [TBL] [Abstract][Full Text] [Related]
34. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Pe'er J; Shweiki D; Itin A; Hemo I; Gnessin H; Keshet E Lab Invest; 1995 Jun; 72(6):638-45. PubMed ID: 7540233 [TBL] [Abstract][Full Text] [Related]
35. Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity. Nakano A; Asano D; Kondo R; Mori A; Arima S; Ushikubo H; Sakamoto K; Nagamitsu T; Ishii K; Nakahara T Exp Eye Res; 2018 Mar; 168():115-127. PubMed ID: 29339088 [TBL] [Abstract][Full Text] [Related]
36. ERK1/2 signaling pathways involved in VEGF release in diabetic rat retina. Ye X; Xu G; Chang Q; Fan J; Sun Z; Qin Y; Jiang AC Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5226-33. PubMed ID: 20445124 [TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy. Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908 [TBL] [Abstract][Full Text] [Related]
38. Role of VEGF-A in endothelial phenotypic shift in human diabetic retinopathy and VEGF-A-induced retinopathy in monkeys. Hofman P; Blaauwgeers HG; Vrensen GF; Schlingemann RO Ophthalmic Res; 2001; 33(3):156-62. PubMed ID: 11340407 [TBL] [Abstract][Full Text] [Related]
39. The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge. Cavallaro G; Filippi L; Bagnoli P; La Marca G; Cristofori G; Raffaeli G; Padrini L; Araimo G; Fumagalli M; Groppo M; Dal Monte M; Osnaghi S; Fiorini P; Mosca F Acta Ophthalmol; 2014 Feb; 92(1):2-20. PubMed ID: 23617889 [TBL] [Abstract][Full Text] [Related]
40. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier. Kim SR; Suh W Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]